glp-1 ban FDA Proposes on Bulk Compounding for Semaglutide, Tirzepatide, and Liraglutide Compass Point's Max Reale talks
Description
It is also not recommended during pregnancy or while breastfeeding

PlexusDx does not sell, prescribe, or recommend any other therapeutic peptide in the GLP-1 category beyond semaglutide and tirzepatide (including dulaglutide, liraglutide, retatrutide, cagrilintide, and related compounds)
It also slows the absorption of mealtime glucose. Semaglutide has been studied for over five years and is proven safe and effective both for individuals with type 2 diabetes and for those with obesity or overweight

10.1056/NEJMoa2032183 90 YangJ.RenJ.SongJ.LiuF.WuC.WangX.et al (2013)

That is the whole game of marketing and advertisement
Packed with 20+ vitamins, minerals, and 6g of fiber, they support gut health, boost energy, and promote overall wellnessall in one effective supplement
